Cmed Clinical Services
Cmed Clinical Services (Cmed CS) is a CRO which provides unique clinical services to drug development organisations world-wide.
The key decision pharmaceutical companies currently face is whether to progress a molecule into phase III, with its attenuated outlay. Biotechnology companies, on the other hand, need to acquire an appropriate data set as quickly as possible to build a strong package for either partnering and / or licensing. Both constituents need to:
- Manage timelines better
- Consider the role of complex protocols
- Be creative in terms of study design, data acquisition and management
- Control costs more efficiently
Through our unique solution of coupling our proprietary e-clinical technology, Timaeus, with our full service trial delivery teams, Cmed CS has the proven ability of being able to provide a bespoke solution to both challenges. We are able to deliver early phase (I to IIb) clinical projects faster and more cost effectively as well as conduct complex studies smoothly.
Leveraging our distinctive solution, Cmed CS provides our clients with:
- Rapid project build and start-up
- Access to all potential investigators
- Greatly increased investigator motivation
- Enhanced patient / subject recruitment
- Accelerated project close-out
Our vision is to provide our unique capabilities to customers so they can collect the right data at the right time in order to make the right decision.
Cmed CS has successfully delivered over 300 clinical projects across all phases of development, but our speciality is early phase (I to IIb). These projects have been both traditional and complex, such as adaptive trials, proof of concept, and multi-cohort. Whilst we have delivered projects across a variety of indications, we have experience, expertise and a great track record in the field of oncology.
